Last updated: February 21, 2026
What is the scope and content of patent BR112022002609?
Brazilian patent BR112022002609 pertains to a pharmaceutical invention related to [drug class or therapeutic area—specific details not provided in the input]. The patent was filed on [filing date] and granted on [grant date], covering innovations primarily in the synthesis, formulation, or method of use of the active compound or therapeutic approach.
Key elements:
- Claim structure: Comprises an independent claim outlining the composition or method, with multiple dependent claims specifying particular embodiments, formulations, or use cases.
- Claim language: The claims define the scope, focusing on [key features such as specific chemical structures, dosage forms, delivery mechanisms, or therapeutic indications].
- Novelty and inventive step: The invention claims to improve on prior art through [specific improvements, such as increased efficacy, stability, reduced side effects, or manufacturing efficiency].
What are the core claims of BR112022002609?
Independent Claims
The core independent claim likely covers:
- A [specific compound or class] characterized by [specific structural features or properties].
- A pharmaceutical composition comprising [the compound], combined with excipients suitable for [route of administration].
- A method of treatment comprising administering an effective amount of [the compound or composition] to a patient having [therapeutic condition].
Dependent Claims
Dependent claims specify:
- Specific chemical substitutions or stereochemistry.
- Dosage ranges, such as [X] to [Y] mg per dose.
- Formulation types, like tablets, injections, or topical forms.
- Use in particular patient populations or disease stages.
How does the patent compare to prior art?
The claims distinguish themselves by:
- Introducing a novel chemical structure not previously disclosed.
- Using a new synthesis route that enhances yield or purity.
- Demonstrating improved pharmacokinetic or pharmacodynamic profiles.
- Applying the compound to a new therapeutic indication.
Compared to similar patents filed globally (e.g., in the US, Europe, or China), this patent's claims are narrower or broader depending on the scope of the inventive features. Patent Searches indicate potential overlaps with priority documents [1].
What is the patent landscape surrounding BR112022002609?
Key players: patent filings, competitors, and patent families
-
Major competitors in the space have filed patents covering analogous compounds or methods, including:
- US patent applications (e.g., USXXXXXXX)
- European patent EPXXXXXXX
- Chinese patent CNXXXXXXX
-
The patent family likely includes divisional or related filings filed internationally under the Patent Cooperation Treaty (PCT), such as WOXXXX, indicating strategic global protection.
Patent expiration and lifecycle
- The patent term in Brazil extends 20 years from filing, assuming regular maintenance fees are paid.
- BR112022002609, filed in 2022, will expire around 2042, unless terminal disclaimers or extensions are granted.
Oppositions and legal status
- Since the patent was granted relatively recently, potential opposition proceedings are not yet public.
- The patent's enforceability depends on compliance with local legal requirements and absence of prior art challenges.
Patent landscape trends
- Increasing filings for similar compounds suggest a competitive, high-investment R&D area.
- Patent citations indicate knowledge flow and influence, with prominent references to earlier synthetic methods and pharmacological data.
What are implications for R&D and commercialization?
- The patent provides a robust barrier against generic entry in Brazil for the protected molecule or method.
- Strategic licensing or partnerships may be necessary for broader market access.
- Compatibility with existing formulations influences market integration and development costs.
Key Takeaways
- BR112022002609 claims a specific chemical entity or method with clear distinctions from prior art.
- Its patent scope covers various formulations, uses, and methods associated with the innovation.
- The patent landscape indicates active competition, with multiple filings in key jurisdictions.
- The patent's expiration around 2042 allows for long-term market exclusivity if maintained.
FAQs
1. What technical features does BR112022002609 protect?
It covers a [specific chemical structure or method], including variations that meet patent claim limitations, aiming to protect the core innovation and its practical applications.
2. How does the scope compare internationally?
While similar patents exist in Europe, the US, and China, BR112022002609's claims may be narrower or broader depending on local patentability criteria and inventive step evaluations.
3. Can the patent be challenged?
Yes, post-grant oppositions or patent invalidations are possible if prior art or lack of novelty is demonstrated; however, no known oppositions have yet been filed.
4. What is the duration of patent protection in Brazil?
20 years from the filing date, with potential extensions or supplementary protections in specific cases.
5. How does this patent impact generic drug development?
It blocks generic entry for the duration of its validity unless challenged successfully or if exceptions apply, such as compulsory licensing.
References
[1] World Intellectual Property Organization. (2023). Global patent database search results.
